series-b
Stage
1
Investors
About
Alkahest develops plasma-based diagnostics and therapies focused on aging and neurological diseases by identifying factors in human plasma that affect tissue health and function.
Explore Alkahest's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.